CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder [Phase 2]
Summary
A Phase 2 study evaluating the safety, tolerability and efficacy of XEN1101 in major depressive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xenon Pharmaceuticals Inc. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED